Hippocrates Research Swiss offers a boutique CRO model built on 30 years of experience. With a lean, agile structure and senior-level involvement, we transform scientific innovation into strong clinical assets, delivering capital efficiency, strategic focus, and measurable value.
Products, services, technology
We provide full-service clinical research support, including regulatory strategy, clinical operations, medical writing, data management, biostatistics, and medical information. Our integrated, science-driven approach supports Biotech and Medtech companies from development through market readiness.
Cooperation possibilities
We offer flexible cooperation models, from full-service clinical development to functional outsourcing and strategic consulting. We act as a hands-on partner, aligning scientific, regulatory, and business objectives to accelerate development and maximize asset value.
- https://www.hippocrates-research.com
- Send an email
- Filip Rozewski
Some insights
We help bring innovative therapies and medical technologies to patients faster and more efficiently. By ensuring scientific rigor, regulatory compliance, and capital efficiency, we support the development of safe, effective solutions that improve global health outcomes.
We are proud of our scientific integrity, senior-level expertise, and agile boutique model. By combining over 30 years of experience with hands-on execution, we deliver high-quality clinical solutions that create real value for our partners and ultimately benefit patients worldwide.
Our core strengths include senior clinical leadership, regulatory expertise, strategic planning, and hands-on operational excellence. We are already implementing digital capabilities through dedicated AI platforms for clinical research to further enhance efficiency, quality, and strategic insight.
Stronger collaboration between biotech, investors, and research institutions would support us best. Facilitating early strategic dialogue, funding access, and innovation partnerships would accelerate clinical development and strengthen Switzerland’s position in global life sciences.
We seek to connect with biotech and medtech innovators, investors, venture capital funds, academic research centers, and strategic industry partners interested in efficient clinical development and value-driven collaboration.
